Catalent Completes $4.6 Million Expansion at Singapore Clinical Supply Facility

Catalent Completes $4.6 Million Expansion at Singapore Clinical Supply Facility

Mar 02, 2018PR-M03-18-NI-008

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the completion of a two-year, $4.6 million expansion at its Singapore clinical supply facility. The company made the announcement at the PHAR-EAST Pharma and Biotech Festival, which is currently taking place at the Suntec Singapore Convention & Exhibition Centre.

The site has seen significant growth since opening in 1998, almost tripling in size and now standing at almost 20,000-square foot, with headcount also tripling since 2012.

“We are particularly pleased to have completed the expansion in a year that marks the 20th anniversary of what was Catalent’s first facility in the Asia-Pacific region,” commented Bernie Clark, VP Marketing, Catalent Clinical Supply Services. He added, “Supported by many long-serving employees, the Singapore site has undergone tremendous growth over the past two decades and now routinely distributes to 18 countries in the region.”

With facilities in the U.S., U.K., Germany, Japan and China, and an extended network of over 50 audited depots, Catalent’s clinical supply services business has the capability and expertise to handle a broad range of international compliance and distribution requirements, that can help to expedite clinical trials and ensure that customers are reliably supplied where and when needed around the globe.



Contacts
Chris Halling 
Catalent Pharma Solutions 
+44 +44 7580 041073

Richard Kerns 
Northern Exposure Public Relations Ltd 
+44 161 728 5880